Updated Jul 16, 2026
RAMSAY DAVID A has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $704K. Lifetime open-market sales: $121K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | HALO | HALOZYME THERAPEUTICS, INC. | F — Tax withholding / forfeiture | 5.4K | $78.27 | $423K |
| 2026-07-02 | HALO | HALOZYME THERAPEUTICS, INC. | M — Option exercise | 10.0K | $0.00 | |
| 2025-12-19 | SVRA | Savara Inc | S — Open-market sale | 20.0K | $6.06 | $121K |
| 2025-12-11 | SVRA | Savara Inc | A — Grant or award | 40.0K | $0.00 | |
| 2025-03-31 | SVRA | Savara Inc | P — Open-market purchase | 150.0K | $2.77 | $416K |
| 2024-12-16 | SVRA | Savara Inc | A — Grant or award | 40.0K | $0.00 | |
| 2024-11-18 | SVRA | Savara Inc | P — Open-market purchase | 100.0K | $2.88 | $288K |
RAMSAY DAVID A is a corporate insider — currently tracked as EVP, PRESIDENT, DRUG DELIVERY of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($704K) and 1 open-market sales ($121K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RAMSAY DAVID A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.